Buyer's remorse at AbbVie
  • 5 years ago
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs

AbbVie is considering abandoning its deal with Shire because of a US clampdown on so-called tax inversions. Lex's Robert Armstrong and Oliver Ralph discuss the logic of the pharma tie-up and why the sums may no longer add up.

Make better investment decisions with Lex
http://www.ft.com/lex

Click here for more Lex videos
http://video.ft.com/Lex

For more video content from the Financial Times, visit http://www.FT.com/video

Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes